Michael Aven
25Patents
6h-index
25Co-inventors
69Inventor score
Filing activity: Mar 15, 1999 → Oct 26, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6613806B1 | Enhancement of the efficacy of benzoylbenzenes | Human Necessities | 25 | Expired |
| US6383984B1 | Aqueous suspension concentrate | Human Necessities | 21 | Expired |
| US6124301A | Enhancement of the efficacy of triazolopyrimidines | Human Necessities | 16 | Expired |
| US6566308B1 | Emulsifiable concentrate containing one or more pesticides and adjuvants | Human Necessities | 11 | Expired |
| US6444618B1 | Crop protection emulsifiable concentrate containing defoaming agents | Human Necessities | 8 | Expired |
| US6165940A | Non-aqueous suspension concentrate | Human Necessities | 8 | Expired |
| US6387848B1 | Non-aqueous concentrated spreading oil composition | Human Necessities | 4 | Expired |
| US6872736B1 | Non-aqueous emulsifiable concentrate formulation | Human Necessities | 3 | Expired |
| US9474747B2 | Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses | Human Necessities | 3 | Active |
| US7176209B2 | Fungicidal formulation | Human Necessities | 1 | Expired |
| US10046124B2 | Inhaler | Performing Operations; Transporting | 1 | Active |
| US11185590B2 | Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition | Human Necessities | 1 | Active |
| US9918995B2 | Ciclesonide for the treatment of airway disease in horses | Human Necessities | 1 | Active |
| US10071162B2 | Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition | Human Necessities | 1 | Active |
| US10925964B2 | Pharmaceutical formulation comprising ciclesonide | Human Necessities | 0 | Active |
| US6596775B2 | Enhancement of the efficacy of benzoylbenzenes | Human Necessities | 0 | Expired |
| US11819549B2 | Pharmaceutical formulation comprising ciclesonide | Human Necessities | 0 | Active |
| US12357696B2 | Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition | Human Necessities | 0 | Active |
| US11679212B2 | Inhaler | Performing Operations; Transporting | 0 | Active |
| US10258634B2 | Ciclesonide for the treatment of airway disease in horses | Human Necessities | 0 | Active |
| US10682345B2 | Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses | Human Necessities | 0 | Active |
| US10441597B2 | Ciclesonide for the treatment of airway disease in horses | Human Necessities | 0 | Active |
| US10603451B2 | Container for an inhaler | Performing Operations; Transporting | 0 | Active |
| US10342789B2 | Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses | Human Necessities | 0 | Active |
| US6894003B2 | Enhancement of the activity of carotenoid biosynthesis inhibitor herbicides | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.